Logo

OpiCalc

FavoritesSpecialtiesDrugsGuidelinesMost Used

All Specialties

OpiCalc Logo
FavoritesSpecialtiesDrugsGuidelinesMost Used
FavesSpecsDrugsGuidesTop
ABCD ScoreAdjusted Body WeightBody Mass IndexDiaRem ScoreIdeal Weight & Excess Weight Loss
OpiCalc Logo

OpiCalc

Easy, fast, and private medical tools for clinicians. Always free.

No Login Required
Ready for the Bedside

Resources

About UsEditorial PolicyMedical DisclaimerPrivacy PolicyTerms of UseCookie Policy

Support

Contact Us

Clinical Notice:OpiCalc is not a substitute for professional clinical judgment. Always verify dosages and guidelines.

OpiCalc © 2018-2026

•

All Rights Reserved

Recent Journal Updates

British J Clinical PharmacologyJun 26, 2026
Linezolid‐induced lactic acidosis in critically ill patients: A multicentre study of incidence, severity and predictors

Clinical Context

We think this might be relevant to the clinical guidance for ABCD Score — T2DM Remission Predictor.

JAMAJun 23, 2026
Metabolic Bariatric Surgery Declines as GLP-1 Drug Use Increases

Clinical Context

We think this has broad domain relevance to ABCD Score — T2DM Remission Predictor.

WHO NewsJun 23, 2026
WHO urges scale up of newborn screening to improve early detection and care of birth defects

Clinical Context

We think this has broad domain relevance to ABCD Score — T2DM Remission Predictor.

ABCD Score

ABCD Score: Evidence-based predictor of Type 2 Diabetes remission after metabolic surgery. Based on Lee et al., Surg Obes Relat Dis, 2013.

Yrs
kg/m2
ng/mL
Yrs
Guidelines & Evidence

Verified

Last Review: 2026

When to Use

When to Use

Pre-operative counselling for bariatric surgery candidates with T2DM
Procedure selection — estimating T2DM remission probability across RYGB, LSG, and LAGB
Setting realistic expectations before surgery in insulin-requiring patients
Clinical documentation of anticipated surgical benefit for payers and multidisciplinary teams
Identifying candidates unlikely to achieve remission despite surgery

Patient Population

Validated in adult patients with established T2DM who are candidates for metabolic/bariatric surgery. Not intended for patients without a T2DM diagnosis or those undergoing revisional surgery.

Last Comprehensive Review: 2026